TY - JOUR
T1 - A content review of online naloxone Continuing Education courses for pharmacists in states with standing orders
AU - Carpenter, Delesha M.
AU - Roberts, Courtney A.
AU - Westrick, Salisa C.
AU - Ferreri, Stefanie P.
AU - Kennelty, Korey A.
AU - Look, Kevin A.
AU - Abraham, Olufunmilola
AU - Wilson, Courtenay
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/10
Y1 - 2018/10
N2 - Background: Many community pharmacists are uncomfortable educating patients about naloxone, an opioid reversal agent. Objective: To examine whether training materials prepare pharmacists to counsel patients and caregivers about naloxone, online naloxone education materials for pharmacists in the 13 states with standing orders were analyzed. Methods: Two coders reviewed 12 naloxone training programs and extracted data for 15 topics that were clustered in four categories: background/importance, naloxone products, business/operations, and communication. Programs that included communication content were coded for whether they: 1) suggested specific verbiage for naloxone counseling; 2) recommended evidence-based communication practices; and 3) included example naloxone conversations. Results: Most programs covered the majority of topics, with the exception of extended treatment for individuals who overdose and naloxone storage/expiration information. Eleven programs addressed pharmacist-patient communication, although information on communication was often limited. Only one program included an example pharmacist-patient naloxone conversation, but the conversation was 10 min long and occurred in a private room, limiting its applicability to most community pharmacies. Conclusions: Online naloxone training materials for pharmacists include limited content on how to communicate with patients and caregivers. Training materials that include more in-depth content on communication may increase pharmacists' confidence to discuss the topics of overdose and naloxone.
AB - Background: Many community pharmacists are uncomfortable educating patients about naloxone, an opioid reversal agent. Objective: To examine whether training materials prepare pharmacists to counsel patients and caregivers about naloxone, online naloxone education materials for pharmacists in the 13 states with standing orders were analyzed. Methods: Two coders reviewed 12 naloxone training programs and extracted data for 15 topics that were clustered in four categories: background/importance, naloxone products, business/operations, and communication. Programs that included communication content were coded for whether they: 1) suggested specific verbiage for naloxone counseling; 2) recommended evidence-based communication practices; and 3) included example naloxone conversations. Results: Most programs covered the majority of topics, with the exception of extended treatment for individuals who overdose and naloxone storage/expiration information. Eleven programs addressed pharmacist-patient communication, although information on communication was often limited. Only one program included an example pharmacist-patient naloxone conversation, but the conversation was 10 min long and occurred in a private room, limiting its applicability to most community pharmacies. Conclusions: Online naloxone training materials for pharmacists include limited content on how to communicate with patients and caregivers. Training materials that include more in-depth content on communication may increase pharmacists' confidence to discuss the topics of overdose and naloxone.
KW - Education
KW - Health communication
KW - Naloxone
KW - Opioids
KW - Pharmacists
UR - http://www.scopus.com/inward/record.url?scp=85034849378&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034849378&partnerID=8YFLogxK
U2 - 10.1016/j.sapharm.2017.11.011
DO - 10.1016/j.sapharm.2017.11.011
M3 - Article
C2 - 29239777
AN - SCOPUS:85034849378
SN - 1551-7411
VL - 14
SP - 968
EP - 978
JO - Research in Social and Administrative Pharmacy
JF - Research in Social and Administrative Pharmacy
IS - 10
ER -